MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer
Yongbao Wei(Second Xiangya Hospital of Central South University), Wang Zhao(Second Xiangya Hospital of Central South University)
Cited by 108
Related Papers
Current Treatment for Low-Risk Prostate Cancer in China: A National Network Survey
|Journal of Cancer|2019|11
Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin
|Molecular Medicine Reports|2015|8
Gourd-Shaped Bladder Associated with Ketamine Abuse
|Urologia Internationalis|2012|4